Bioresonance Therapy – Diagnostic Wonder or Expensive Placebo?

The Principle of Bioresonance

Bioresonance devices (most well-known model: MORA, developed in Germany in the 1970s) are based on the idea that the body emits pathological electromagnetic oscillations. The device supposedly reads these, inverts them (phase reversal), and sends them back – thereby "canceling out" "sick oscillations."

Physically: A phase reversal of electromagnetic signals is real (noise-cancelling headphones work this way). Whether diseases have specific, measurable EM signatures that can be reliably read and inverted is not scientifically established.

Anecdotes vs. Clinical Studies

Bioresonance is marketed for allergies, smoking cessation, weight reduction, and – concerningly – as an alternative diagnostic tool. There are many positive user reports. Controlled studies with objective endpoints show a different picture:

Pilot study on smoking cessation (Trinidade et al.): No significant difference from placebo after 12 months
Allergy test validation: Bioresonance test results do not reproducibly correlate with IgE blood tests or prick tests

Official Warnings from FDA & MSKCC

The Memorial Sloan Kettering Cancer Center (New York) explicitly warns against bioresonance as a cancer diagnostic method: Misdiagnoses can delay life-saving therapies. The FDA has issued multiple import bans against bioresonance devices marketed as diagnostic or therapeutic devices without clinical evidence.

Portal Conclusion

Bioresonance sessions can have a relaxing effect – through the placebo effect, relaxation response, and therapeutic attention. That is not nothing. But as a diagnostic tool or as an alternative to laboratory blood panels, bioresonance is not suitable and can be dangerous – if it conceals serious conditions or delays treatment. Frequency Healings recommends: Bioresonance at most as a relaxing complement, never as diagnostics.